The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Share

Personal info

View

Links

Table of contents

Affiliations

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Martin Busch

Department of Internal Medicine III

University of Jena

Germany

[email]@med.uni-jena.de

Name/email consistency: high

[Claim this account]

Affiliations

Department of Internal Medicine III, University of Jena, Germany. 2004 - 2010
Department of Internal Medicine III and Institute of Medical Statistics and Computer Sciences, University of Jena, Germany. 2006

References

Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease. Busch, M., Göbert, A., Franke, S., Ott, U., Gerth, J., Müller, A., Stein, G., Bitsch, R., Wolf, G. Nephron. Clin. Pract (2010) [Pubmed]
Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension. Busch, M., Franke, S., Wolf, G., Rohde, R.D., Stein, G. Nephron. Clin. Pract (2008) [Pubmed]
The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension. Busch, M., Franke, S., Wolf, G., Brandstädt, A., Ott, U., Gerth, J., Hunsicker, L.G., Stein, G. Am. J. Kidney Dis. (2006) [Pubmed]
Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Busch, M., Franke, S., Müller, A., Wolf, M., Gerth, J., Ott, U., Niwa, T., Stein, G. Kidney Int. (2004) [Pubmed]

WikiGenes - Universities